HDAC2 selective inhibitor (Quimatryx)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameHDAC2 selective inhibitor (Quimatryx)

Drug Alias NameHDAC2 selective inhibitor (Ikerchem)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistone deacetylase 2 inhibitors

TargetsHistone deacetylase 2

Therapy Area/IndicationsCentral Nervous System DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesQuimatryx

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesQuimatryx

Active IndicationsN/A

Inactive IndicationsCentral Nervous System DiseasesNeoplasms

ATC CodeN/A